Keyword

hemoglobin response

Description: The change in hemoglobin level following treatment, used to assess therapeutic effects in anemia and related conditions.

Primary topic: Erythropoietin and Anemia Treatment (50%)

OpenAlex ID: keywords/hemoglobin-response

Effect of Human Erythropoietin Derived From Recombinant Dna on the Anaemia of Patients Maintained by Chronic Haemodialysis

1986 · ChristopherG Winearls, MartinJ Pippard, et al. · The Lancet · 1,401

Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

2015 · Steven P. Treon, Christina K. Tripsas, et al. · New England Journal of Medicine · 942

PDF

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

2019 · Elliott Vichinsky, Carolyn C. Hoppe, et al. · New England Journal of Medicine · 626

PDF

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

2001 · Janice L. Gabrilove, Charles S. Cleeland, et al. · Journal of Clinical Oncology · 595

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

2002 · Neal J Weinreb, Joel Charrow, et al. · The American Journal of Medicine · 546

Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle

2005 · Shalender Bhasin, Linda Woodhouse, et al. · The Journal of Clinical Endocrinology & Metabolism · 545

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

2016 · Iain C. Macdougall, Andreas J. Bircher, et al. · Kidney International · 482

PDF

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

2002 · J. Vansteenkiste · JNCI Journal of the National Cancer Institute · 477

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

2010 · Scott D. Solomon, Hajime Uno, et al. · New England Journal of Medicine · 472

PDF

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

2010 · Min Lu, Martin H. Cohen, et al. · American Journal of Hematology · 443

PDF

Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

1990 · Heinz Ludwig, Elke Fritz, et al. · New England Journal of Medicine · 443

PDF

A randomized controlled study of iron supplementation in patients treated with erythropoietin

1996 · Iain C. Macdougall, Beatriz Tucker, et al. · Kidney International · 417

Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial

2004 · Michael Auerbach, Harold Ballard, et al. · Journal of Clinical Oncology · 414

Erythropoietin or darbepoetin for patients with cancer

2012 · Thomy Tonia, Annette Mettler, et al. · Cochrane Database of Systematic Reviews · 413

PDF

Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin Saturation

2007 · Daniel W. Coyne, Toros Kapoian, et al. · Journal of the American Society of Nephrology · 391

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

2011 · Rayko Evstatiev, Philippe Marteau, et al. · Gastroenterology · 367

PDF

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ® ) Randomized Controlled Trial

2008 · Stefanie Kulnigg, Simeon Stoinov, et al. · The American Journal of Gastroenterology · 349

Clinical Outcomes and CD4 Cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia

2007 · Carolyn Bolton-Moore, Mwangelwa Mubiana-Mbewe, et al. · JAMA · 337

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

2014 · I. C. Macdougall, A. H. Bock, et al. · Nephrology Dialysis Transplantation · 328

PDF

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer

2004 · C. Bokemeyer, M.S. Aapro, et al. · European Journal of Cancer · 327

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

2003 · Michael Hedenus, Magnus Adriansson, et al. · British Journal of Haematology · 326

PDF

Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis

2016 · Daniel Shepshelovich, Benaya Rozen-Zvi, et al. · American Journal of Kidney Diseases · 322

Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies

2002 · A. Österborg, Y. Brandberg, et al. · Journal of Clinical Oncology · 310

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

2017 · Uwe Platzbecker, Ulrich Germing, et al. · The Lancet Oncology · 291

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

2016 · Robert Provenzano, Anatole Besarab, et al. · Clinical Journal of the American Society of Nephrology · 290

Works count: 3,669

Citation count: 62,150